When was Thynk Health founded?

Thynk Health was founded in 2014 and raised its 1st funding round 5 years after it was founded.

Where is Thynk Health located?

Thynk Health is headquartered in Lexington, United States.

Who is the current CEO of Thynk Health?

Jeffrey Markowitz of Thynk Health.

How many employees does Thynk Health have?

As of Jul 31, 2026, the latest employee count at Thynk Health is 10.

Is Thynk Health a funded company?

Thynk Health is a funded company, having raised a total of $2.49M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 08, 2019.

When was the latest funding round of Thynk Health?

Thynk Health's latest funding was a $***** Seed round on Sep 28, 2023, with participation from 0 investor.

Where does Thynk Health rank among its competitors?

Thynk Health ranks 100th amongst 767 active competitors, of which 170 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Carpl, which secured $10M in Jul, 2026.

Who are the top competitors of Thynk Health?

Thynk Health's top competitors include AIdoc, Subtle Medical and ScreenPoint. Among them, Carpl secured the most recent funding round in July, 2026.

Thynk Health - 2026 Company Profile, Team, Funding & Competitors

Thynk Health is an acquired company based in Lexington (United States), founded in 2014. It operates as a Provider of lung cancer screening platform. Thynk Health has raised $2.49M in funding. The company has 767 active competitors, including 170 funded and 41 that have exited. Its top competitors include companies like AIdoc, Subtle Medical and ScreenPoint.

Company Details

Provider of lung cancer screening platform. The company has developed software to optimize the EHR of patients for lung cancer screening. The AI-based technology automates and analyses the data abstraction, data entry, and communication data to improve the health outcomes of the patients. It also provides Epic app Orchard, a SaaS based subscription for using the Lung screening module.

Website: www.thynkhealth.com/
Social
Email ID: *****@thynkhealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Lexington, United States

Stage

Acquired

Total Funding

$2.49M in 4 rounds

Latest Funding Round

Seed, Sep 28, 2023, $*****

Investors

Bluegrass Angels & 2 more

Ranked

100^th among 767 active competitors

Employee Count

10 as on Jul 31, 2026

Similar Companies

ScreenPoint & 656 more

Exit Details

Acquired by Azra (Apr 28, 2026)

View Thynk Health's full profile

Thynk Health is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Thynk Health, LLC CIN: 465692889 , United States, Active	Dec 31, 2013	-	14 (As on Dec 31, 2024)	-

Thynk Health got acquired by Azra on Apr 28, 2026.

Click here to take a look at Thynk Health's acquisition in detail

Thynk Health has raised a total funding of $2.49M over 4 rounds. Its first funding round was on Jan 08, 2019. Thynk Health has 3 institutional investors.

Here is the list of recent funding rounds of Thynk Health:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 28, 2023	5616977	Seed	6145299	5681189	7428629	9250201
Nov 29, 2021	8822943	Seed	1070084	3225254	6063302	2464291
Jan 08, 2019	2052411	Grant (prize money)	8902953	4106924	5917068	Lexington-Fayette Urban County Government

Access funding benchmarks and valuations. Sign up today!

View details of Thynk Health's funding rounds and investors

Thynk Health's employee count trend

Thynk Health has 10 employees as of Jul 26. Here is Thynk Health's employee count trend over the years:

Uncover Thynk Health's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Thynk Health include AIdoc, Subtle Medical and ScreenPoint. Here is the list of Top 10 competitors of Thynk Health, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	AIC, General Catalyst & 35 others	69/100
2nd	Subtle Medical 2017, Palo Alto (United States), Series C	AI-driven solutions for medical diagnostic imaging	$86M	3E Bioventures Capital, Bessemer Venture Partners ... & 27 others	65/100
3rd	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Insight Partners, Siemens & 3 others	64/100
4th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
5th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Open Field Capital, Khosla Ventures & 12 others	62/100
6th	Carpl 2018, Delhi (India), Series A	AI-powered radiology and deployment platform	$16M	Stellaris, IFC & 7 others	62/100
7th	IXICO 2004, London (United Kingdom), Public	AI-based medical image management and analysis solutions for healthcare organizations	-	Leonne International, IP Group & 3 others	62/100
8th	Vara 2016, Berlin (Germany), Series A	Provider of AI-based breast cancer screening software for clinics	$20.3M	FJH, IBB Ventures & 12 others	61/100
9th	Us2.ai 2017, Singapore (Singapore), Series A	AI-powered tool for the detection of heart risk	$19.1M	EDBI, IHH Healthcare Berhad & 15 others	61/100
10th	AI Medical Service 2017, Toshima City (Japan), Series C	AI-powered endoscopic software to detect early-stage gastrointestinal cancers	$122M	SoftBank Vision Fund, Globis Capital Partners ... & 11 others	60/100
100th	Thynk Health 2014, Lexington (United States), Acquired	Provider of lung cancer screening platform	$2.49M	Bluegrass Angels, Global Equity Ventures & 1 others	41/100